Shots: The approval is based on P-II CITN-09/KEYNOTE-017 study assessing Keytruda in 50 patients with recurrent LA or mMCC who had not received prior systemic therapy P-II CITN-09/KEYNOTE-017 study results: […]readmore
Tags : Merkel Cell Carcinoma
Shots: The sBLA is based on P-II KEYNOTE-017 study including ORR and DOR for 1L merkel cell carcinoma(MCC), study shows most DTC in MCC patients The US has set a […]readmore